tiprankstipranks
N4 Pharma (GB:N4P)
:N4P
UK Market

N4 Pharma (N4P) Technical Analysis

Compare
3 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
N4 Pharma’s (N4P) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting N4 Pharma is a Buy.
N4 Pharma’s (N4P) 20-Day exponential moving average is 0.57, while N4 Pharma’s (N4P) share price is 0.52p, making it a Sell.
N4 Pharma’s (N4P) 50-Day exponential moving average is 0.59, while N4 Pharma’s (N4P) share price is 0.52p, making it a Sell.

N4 Pharma (N4P) Pivot Points

Mar 03, 2025, 10:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.47
0.48
0.50
0.52
0.54
0.55
0.57
Fibonacci
0.48
0.50
0.50
0.52
0.53
0.54
0.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

N4 Pharma (N4P) Moving Averages

Mar 03, 2025, 10:18 PM
Period
Simple
Exponential
MA5
0.54Sell
0.54Sell
MA10
0.56Sell
0.55Sell
MA20
0.57Sell
0.57Sell
MA50
0.60Sell
0.59Sell
MA100
0.61Sell
0.60Sell
MA200
0.57Sell
0.61Sell
N4 Pharma’s (N4P) 10-Day exponential moving average is 0.55, while N4 Pharma’s (N4P) share price is 0.52p, making it a Sell.
N4 Pharma’s (N4P) 100-Day exponential moving average is 0.60, while N4 Pharma’s (N4P) share price is 0.52p, making it a Sell.
N4 Pharma’s (N4P) stock price is 0.52p and N4 Pharma’s (N4P) 50-day simple moving average is 0.60, creating a Sell signal.
N4 Pharma’s (N4P) stock price is 0.52p and N4 Pharma’s (N4P) 100-day simple moving average is 0.61, creating a Sell signal.
N4 Pharma’s (N4P) stock price is 0.52p and N4 Pharma’s (N4P) 200-day simple moving average is 0.57, creating a Sell signal.

N4 Pharma (N4P) Technical Indicators

Mar 03, 2025, 10:18 PM
Name
Value
Implied Action
RSI (14)
34.77
Neutral
STOCH (9,6)
20.00
Buy
STOCHRSI (14)
10.00
Buy
MACD (12,26)
-0.02
Buy
ADX (14)
16.68
Buy
Williams %R
-90.00
Buy
CCI (14)
-178.40
Buy
ATR (14)
0.06
-
Ultimate Oscillator
47.60
Neutral
ROC
-10.34
Sell
N4 Pharma’s (N4P) Relative Strength Index (RSI) is 34.77, creating a Neutral signal.
N4 Pharma’s (N4P) Trend Strength Indicator (ADX) is 16.68, creating a Buy signal.
N4 Pharma’s (N4P) Commodity Channel Index (CCI) is -178.40, creating a Buy signal.
N4 Pharma’s (N4P) Price Rate of Change (ROC) is -10.34, creating a Sell signal.

FAQ

Is N4P a Buy, Hold, or Sell?
Based on N4P’s technical indicators, N4P is a Sell.
    What is N4P’s RSI (14)?
    N4P’s RSI (14) is 34.77, which suggests N4P is a Neutral.
      What is N4P’s MACD?
      N4P’s MACD is -0.02, which suggests N4P is a Buy.
        What is N4P’s 5-day moving average?
        N4P’s 5-day moving average is 0.54, which suggests N4P is a Sell.
          What is N4P’s 20-day moving average?
          N4P 20-day moving average is 0.57, which suggests N4P is a Sell.
            What is N4P’s 50-day moving average?
            N4P’s 50-day moving average is 0.60, which suggests N4P is a Sell.
              What is N4P’s 200-day moving average?
              N4P’s 200-day moving average is 0.57, which suggests N4P is a Sell.
                What is N4P’s Williams % R (14)?
                N4P’s Williams % R (14) is -90.00, which suggests N4P is a Buy.
                  What is N4P’s CCI (14)?
                  N4P’s CCI (14) is -178.40, which suggests N4P is a Buy.
                    What is the share price of N4 Pharma?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis